Cite
APA Citation
Depypere, H., Timmerman, D., Donders, G., Sieprath, P., Ramael, S., Combalbert, J., Hoveyda, H. R., & Fraser, G. L. (2017). clinical evaluation of the NK3 receptor antagonist fezolinetant (a.k.a. ESN364) for the treatment of menopausal hot flashes. Maturitas, 103, 89–90. http://access.bl.uk/ark:/81055/vdc_100047877999.0x000046